Combined nasal CPAP(nCPAP)and inhaled nitric oxide(iNO)for moderate RDS of the newborn: effects from

• 作 者: R LINDWALL E BERGGREN M BLENNOW M FLANBY C FROSTELL B JONSSON P-A LONNQVIST M NORMAN M SVENSSON
• 机 构: Department of Anesthesia and Intensive Care, Karolinska Institutet, Danderyd Hospital Stockholm, Swe
• 出 处: Acta Pharmacologica Sinica
• 发表日期: 2003年12期
• 关键词: CPAP newborn nasal moderate ventilation administration exposure minutes concomit

Treatment with iNO has so far mainly been described and approved for delivery during endotracheal intubation and mechanical ventilation. We have recently validated a modified nasal CPAP(nCPAP) svstem for the concomitant administration of iNO to infants. AIM: To evaluate the feasibilicy of this delivery system in clini-

Treatment with iNO has so mainly been described and approved for delivery during endotracheal intubation and mechanical ventilation. We have recently validated a modified nasal CPAP (nCPAP) svstem for the concomitant administration of iNO to infants. AIM: To evaluate the feasibilicy of this delivery system in clini-